Cognitive Decline, COVID-19, SARS CoV 2 Infection
Conditions
Brief summary
COVID-19 has swept the world, and while some people may experience long-term cognitive decline as a result of infection, no effective treatment has been announced. The primary goal of this study was to determine the efficacy of hyperbaric oxygen therapy in patients with SARS-CoV-2 infection, as well as to assess the effect of hyperbaric oxygen therapy on brain function in patients with COVID-19-related cognitive decline. In this study, approximately 80 people were randomly assigned to either hyperbaric oxygen or regular oxygen therapy to compare the effects of these two treatments on disease.
Detailed description
80 patients with cognitive impairment following a novel coronavirus infection will be randomly assigned to one of two treatment groups: hyperbaric oxygen therapy or conventional oxygen therapy. After the intervention, the improvement of hyperbaric oxygen on cognition, fatigue, sleep disorders, anxiety and depression, and other clinical manifestations was observed. The neurologic function of hyperbaric oxygen in the treatment of patients with cognitive decline after SARS-CoV-2 infection was also evaluated from imaging and electrophysiological multi-dimensional indexes.
Interventions
PROCEDUREhyperbaric oxygen therapy
The hyperbaric oxygen group was given 60 minutes of pure oxygen under 2ATA (Atmosphere Absolute, ATA) and 5 minutes of rest in between.
PROCEDUREconventional oxygen therapy
Conventional oxygen therapy group breathed 27% oxygen at 1.03 ATA for 60 minutes. (The chamber pressure was increased to 1.2ATA with circulating air noise for the first 5 minutes of the experiment, then reduced to 1.03 ATA for the next 5 minutes.)
Sponsors
The First Affiliated Hospital of Zhejiang Chinese Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Out-patients 4 weeks after the diagnosis of SARS-CoV-2 infection * Subjective cognitive decline after SARS-CoV-2 infection * SARS-CoV-2 nucleic acid/antigen test negative.
Exclusion criteria
* Contraindications to hyperbaric oxygen therapy * Cognitive decline can be explained by other diseases * Conditions that researchers consider unsuitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| scores of Montreal Cognitive Scale (MoCA) | The patients would be followed up for 3 months after oxygen therapy. | The total score is 30 points, and the cut-off value for MCI is identified:≤19 points(illiterate and primary school group);≤22 points(Middle school group); ≤24 points(University group). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Brain magnetic resonance imaging (MRI), brain functional magnetic resonance imaging (fMRI) | The patients would be followed up for 3 months after oxygen therapy. | The time series acquired from resting-state fMRI will be transformed into the frequency domain using Fast Fourier transform, and the square root of the power spectrum will be calculated and averaged across 0.01-0.08 Hz within each voxel.The ALFF of each voxel will be divided by the global mean ALFF value to standardize data across subjects. |
| Boston naming test | The patients would be followed up for 3 months after oxygen therapy. | Total score is 30 points.The cut-off values for each group are:≦19(Junior high school education level),≦21(High school education level),≦22(University education level) |
| auditory verbal learning test，AVLT | The patients would be followed up for 3 months after oxygen therapy. | A 12-word list was repeated 3 times, and short-delayed recall was performed after an interval of 3-5 minutes, and long-delayed recall, cued recall and recognition were performed after an interval of 20 minutes. The most sensitive evaluation indexes were long-delayed recall score and recognition score. The auxiliary indexes included immediate recall score, total recall score, recall skills and discrimination. Cut-off values: long delayed recall score ≤5 (50-59 years), ≤4 (60-69 years), ≤3 (70-79 years);Recognition score ≤20 (50-59 years), ≤19 (60-69 years), ≤18 (70-79 years). |
| Quantitative Electroencephalography | The patients would be followed up for 3 months after oxygen therapy. | The main frequency distribution and absolute power spectrum of 4 frequency bands (δ (1-3.9 Hz) , θ (4-7 Hz) , α (8-12.9 Hz) and β (13-30 Hz) were obtained, the θ frequency and the relative power of δ frequency (DTABR = (δ + θ)/(α + β)) were calculated. |
| Animal word fluency (AFT) | The patients would be followed up for 3 months after oxygen therapy. | Subjects were asked to list as many examples of animals as possible within 1 min. Cut-off value: animal fluency score ≤12(junior high school group) , ≤13(senior high school group) , ≤14(university group) |
| Stroop color words test | The patients would be followed up for 3 months after oxygen therapy. | The stroop test lasts for 45 seconds, and the correct number of each test is calculated.Cut-off value: animal fluency score ≤12(junior high school group) , ≤13(senior high school group) , ≤14(university group) |
| The Shape Trail Making Test A and B(STT-A&B) | The patients would be followed up for 3 months after oxygen therapy. | The Shape Trail Making Test A and B(STT-A&B) is divided into two parts: A and B. Each part includes exercises and tests. Part A asks participants to connect random numbers in sequence as quickly as possible. Part B asks participants to connect numbers in sequence alternately. Rating: Mainly record the amount of time spent. Cut-off value: STT-A test questions, 50\ 59 years old ≥70s, 60\ 69 years old ≥80s, 70\ 79 years old ≥100s;STT-B test questions, 50\ 59 years old ≥180s, 60\ 69 years old ≥200s, 70\ 79 years old ≥240s. The longer it takes, the worse it gets. |
Countries
China
Contacts
Primary ContactYan Jiang, M.D.
Backup ContactShan Liu, M.M.
Outcome results
None listed